Asset Sale vs. Stock Sale in Home Care M&A: Which Structure Maximizes Seller Value?

Whether your home care agency is sold as assets or as stock is one of the most consequential structural decisions in any sale. The decision affects:

• Seller after-tax proceeds (often 5%–15% differential)
• Licensure and Medicare/Medicaid provider transfer timeline
• Contract assignability and renegotiation requirements
• Successor liability exposure
• Working capital and balance sheet treatment

Most first-time sellers underestimate how much of their negotiating leverage depends on understanding this choice — and how to convert it into purchase price.

---

Definitions

Asset Sale

The buyer acquires specific assets and assumes specific liabilities of the seller entity. The seller entity continues to exist post-close (typically holding remaining cash, certain liabilities, and being wound down).

Stock Sale

The buyer acquires the equity (stock or LLC interests) of the seller entity. The entity continues with all assets and all liabilities — the only thing that changes is who owns it.

---

Tax Differences (The Core Issue)

Stock Sale Tax Treatment (Seller-Favorable)

• Sellers recognize capital gain on equity sale
• Long-term capital gains rate (currently 20% federal + 3.8% NIIT + state)
• Single layer of tax for C-corp shareholders
• Pass-through tax for S-corps and LLCs

Asset Sale Tax Treatment (Seller-Unfavorable)

• C-corp seller: double tax (corporate level on asset gain, then shareholder level on distribution)
• S-corp seller: single tax but with ordinary income recapture on certain assets
• LLC/partnership seller: typically pass-through, but with ordinary income recapture and potential hot asset issues

For C-corp sellers, the difference between asset sale and stock sale can be 15%+ of purchase price in after-tax proceeds.

338(h)(10) and F-Reorganization

A Section 338(h)(10) election treats a stock sale as an asset sale for federal income tax purposes — giving buyer the basis step-up while preserving legal-form benefits of stock sale.

An F-reorganization achieves similar economics for LLC-taxed targets, allowing tax-free reorganization of the seller entity into a structure that supports an effective asset purchase.

These elections are common in PE-backed home care transactions and require careful pre-close planning.

---

Licensure and CHOW Considerations

Asset Sale Licensure Implications

• Generally requires new state operating licensure
• Requires new Medicare provider number (CMS 855A change of ownership process — full new enrollment in many cases)
• Requires new Medicaid enrollment
• Requires new accreditation in many jurisdictions
• Timeline: often 90–180+ days for full licensure transfer

Stock Sale Licensure Implications

• Existing state licensure typically continues (with CHOW notification)
• Existing Medicare provider number continues with CHOW filing
• Existing Medicaid enrollment continues with CHOW notification
• Existing accreditation typically continues
• Timeline: shorter, primarily notification-driven

In CON states (FL, GA, NY, NJ, CT, MA, IL, etc.), CON-protected licensure is materially easier to preserve through stock sale than to recreate through asset sale. This is one reason CON-state assets often command premium multiples.

---

Contract Assignability

Asset Sale

• Each material contract must be reviewed for assignability
• Anti-assignment clauses require counterparty consent
• Payer contracts often require renegotiation or new contracting
• Real estate leases require landlord consent
• Vendor contracts require vendor consent

Stock Sale

• Existing contracts continue (entity unchanged)
• Change of control provisions in contracts may still trigger consent (especially commercial contracts)
• Payer contracts typically continue without renegotiation

For agencies with extensive payer contract portfolios, stock sale dramatically reduces transition friction.

---

Liability Treatment

Asset Sale

Buyer assumes only specifically identified liabilities. Theoretically, undisclosed liabilities remain with seller. However:

• Successor liability doctrine creates exceptions
• Healthcare successor liability for Medicare/Medicaid recoupment is material
• Product liability and tort claims may follow assets in some jurisdictions
• De facto merger doctrine applies to some asset sales
• ERISA successor liability for pension obligations

Stock Sale

All liabilities continue with the entity. Seller indemnification (and R&W insurance) is the primary protection mechanism for the buyer against undisclosed liabilities.

In practice, the liability differential between asset and stock sale is smaller than first-time sellers assume. R&W insurance has further compressed the differential.

---

When Each Structure Is Used

Asset Sale Common When

• Buyer is acquiring a business unit (not a whole company)
• Significant identified pre-close liabilities (regulatory, litigation)
• Buyer absolutely requires basis step-up and 338(h)(10) is unavailable
• Seller is a C-corp where shareholders accept the double tax
• Distressed transaction
• Licensure is portable / not CON-protected

Stock Sale Common When

• CON-protected licensure is at issue
• Extensive payer contract portfolio
• Tax-favorable to S-corp / LLC sellers
• Clean compliance and litigation history
• Buyer comfortable with R&W as liability protection

---

Negotiating the Structure

The structure decision should not be ceded to buyer preference. Sellers should:

1. Run both structures through tax modeling before LOI negotiations
2. Calculate the after-tax differential between asset and stock for the specific deal
3. Quantify the gross-up required for asset structure to produce equivalent after-tax proceeds to stock
4. Use structure flexibility as a price negotiation lever
5. Push for 338(h)(10) or F-reorg as a middle-ground structure when applicable

In well-negotiated processes, sellers commonly extract a 10%–20% gross-up when accepting buyer-preferred asset structure.

---

CHOW Filing Considerations

For Medicare-certified home health and hospice agencies, the CMS Change of Ownership (CHOW) process is materially different between asset and stock sales:

Asset Sale CHOW

• Treated as new enrollment in many cases
• Full 855A submission required
• Site visit may be required
• Provider number may be issued as new (not transferred)
• Provider Reimbursement Review Board impacts

Stock Sale CHOW

• CHOW notification under 42 CFR 489.18
• Existing provider number continues
• Existing Medicare agreement assigned
• Successor liability for prior overpayments

Both structures trigger CHOW reporting to state Medicaid programs and accreditation organizations.

---

Common Seller Mistakes

1. Accepting buyer’s structural preference without tax modeling. The after-tax differential is often the largest negotiable item in the deal.

2. Not requiring purchase price gross-up for asset structure. Asset structure for buyer benefit should be paid for by buyer.

3. Underestimating CHOW timeline. Asset sale CHOW timing can delay close by months.

4. Overlooking 338(h)(10) availability. This middle-ground structure benefits both parties.

5. Not coordinating with tax counsel early. Structure decision must be modeled before LOI is signed.

6. Treating successor liability as binary. Asset sale does not eliminate all pre-close exposure.

---

How Hendon Partners Helps

Hendon Partners coordinates with seller’s tax counsel from the LOI stage to model after-tax outcomes under each structure, quantify gross-ups required for buyer-preferred structures, and use structural flexibility as a price negotiation lever. The structure decision is too important to defer.

Schedule a confidential conversation about your deal structure →

---

Hendon Partners is a sell-side only home care M&A advisory firm. We coordinate with — but do not provide — tax or legal advice.